MAPK7 p.Pro636Arg
c.1907C>G · VCV3293241
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0861 | likely benign |
|---|---|---|
| REVEL | 0.122 | moderately benign-leaning |
| SaProt | LLR -10.85 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.69 | |
| Regional constraint | o/e 1.11 | unconstrained · MANE · 821 bp · p 0.1 · regional, not allelic |
| Overall | ||
| CADD | 13.14 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00133% | 74,964 |
| European (non-Finnish) | 0.000254% | 393,154 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MAPK7
- Protein
- p.Pro636Arg
- Coding
- c.1907C>G
- MANE Select
- NM_002749
- Type
- single nucleotide variant
- Location
- chr17:19382210 (GRCh38)
- Gene constraint
- LOEUF 0.689 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 66.87 · 14 PDB
- Residue 636
- the 'disordered' region; the 'may not be required for kinase activity; required to stimulate mef2c activity' region
Similar variants
- MAPK7 p.Pro551Ser Benign/Likely benign ★★ same type
- MAPK7 p.Ala288Ser Uncertain significance ★ ⚠ same type
- MAPK7 p.Ala29Gly Uncertain significance ★ ⚠ same type
- MAPK7 p.Ala334Thr Uncertain significance ★ ⚠ same type
- MAPK7 p.Ala348Ser Uncertain significance ★ ⚠ same type
- MAPK7 p.Ala360Val Uncertain significance ★ ⚠ same type
- MAPK7 p.Ala481Ser Uncertain significance ★ ⚠ same type
- MAPK7 p.Ala497Val Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mapk7-p-pro636arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown